Kapil Khanelwal KK article in CNBC-TV18 on investing in 2023 in Healthcare and Lifesciences in India
QuoteUnquote with KK
Kapil Khandelwal KK
Toro Finserve LLP
the foreword written by Brad Smith for Microsoft’s report Governing AI: A Blueprint for India. The first part of the report details five ways India could consider policies, laws, and regulations around AI. The second part focuses on Microsoft’s internal commitment to ethical AI, showing how the company is both operationalizing and building a culture of responsible AI. The final part shares case studies from India demonstrating how AI is already helping address major societal issues in the country.
the foreword written by Brad Smith for Microsoft’s report Governing AI: A Blueprint for India. The first part of the report details five ways India could consider policies, laws, and regulations around AI. The second part focuses on Microsoft’s internal commitment to ethical AI, showing how the company is both operationalizing and building a culture of responsible AI. The final part shares case studies from India demonstrating how AI is already helping address major societal issues in the country.
QuoteUnquote with KK 2023 Season 4 is all about ‘Growing Positively’Kapil Khandelwal (KK)
QuoteUnquote with KK 2023 Season 4 is all about ‘Growing Positively’
Announcement of 2023 Season 4 by QuoteUnquote with KK
Kapil Khandelwal KK
QuoteUnquote with KK
www.kapilkhandelwal.com
QuoteUnquote with KK (Kapil Khandelwal) Season 2 premiers as the first podcas...Kapil Khandelwal (KK)
New on afaqs! on QuoteUnquote with KK (Kapil Khandelwal) Season 2 premiers as the first podcast on Dailyhunt
www.kapilkhandelwal.com
QuoteUnquote with KK
From Telegraph Road to US$50 Billion Digital Health Silk Road : Kapil Khandel...Kapil Khandelwal (KK)
My article in VC Circle on the Digital Health Investment and Opportunities in India Post Covid
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Where is the vision? : Kapil Khandelwal, www.kapilkhandelwal.com Kapil Khandelwal (KK)
My fortnightly column, A Dose of IT that discusses the Bangalore India Bio and its outcomes
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
The bridge to education: Kapil Khandelwal, www.kapilkhandelwal.com Kapil Khandelwal (KK)
My fortnightly column, A Dose of IT that is discussing issues around ICT in health education
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
CIS: Surgeons on steroids: Kapil Khandelwal, www.kapilkhandelwal.com Kapil Khandelwal (KK)
My fortnightly column A Dose of IT discussing on the Computer-aided image-guided surgery (CIS) technology
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Integrative medicine becons ICT vendors: Kapil Khandelwal, www.kapilkhandelwa...Kapil Khandelwal (KK)
My fortnightly column, A Dose of IT that discusses the digital opportunity in integrative medicine in India
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
The Genomic Opportunity: Kapil Khandelwal, www.kapilkhandelwal.com Kapil Khandelwal (KK)
My Fortnightly column, A Dose of IT that discusses the genomic opportunity for creating a Bio Health Network
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
My fortnightly column, A Dose of IT that discusses on various issues to manage chronic diseases in India
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Its time for BDA to wake up to reality : Kapil Khandelwal, www.kapilkhandelwa...Kapil Khandelwal (KK)
My fortnightly column, A Dose of IT discusses on Urban census and public health and well being
Kapil Khandelwal
www.kapilkhandelwal.com
QuoteUnquote with KK
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
QuoteUnquote with KK 2023 Season 4 is all about ‘Growing Positively’Kapil Khandelwal (KK)
QuoteUnquote with KK 2023 Season 4 is all about ‘Growing Positively’
Announcement of 2023 Season 4 by QuoteUnquote with KK
Kapil Khandelwal KK
QuoteUnquote with KK
www.kapilkhandelwal.com
QuoteUnquote with KK (Kapil Khandelwal) Season 2 premiers as the first podcas...Kapil Khandelwal (KK)
New on afaqs! on QuoteUnquote with KK (Kapil Khandelwal) Season 2 premiers as the first podcast on Dailyhunt
www.kapilkhandelwal.com
QuoteUnquote with KK
From Telegraph Road to US$50 Billion Digital Health Silk Road : Kapil Khandel...Kapil Khandelwal (KK)
My article in VC Circle on the Digital Health Investment and Opportunities in India Post Covid
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Where is the vision? : Kapil Khandelwal, www.kapilkhandelwal.com Kapil Khandelwal (KK)
My fortnightly column, A Dose of IT that discusses the Bangalore India Bio and its outcomes
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
The bridge to education: Kapil Khandelwal, www.kapilkhandelwal.com Kapil Khandelwal (KK)
My fortnightly column, A Dose of IT that is discussing issues around ICT in health education
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
CIS: Surgeons on steroids: Kapil Khandelwal, www.kapilkhandelwal.com Kapil Khandelwal (KK)
My fortnightly column A Dose of IT discussing on the Computer-aided image-guided surgery (CIS) technology
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Integrative medicine becons ICT vendors: Kapil Khandelwal, www.kapilkhandelwa...Kapil Khandelwal (KK)
My fortnightly column, A Dose of IT that discusses the digital opportunity in integrative medicine in India
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
The Genomic Opportunity: Kapil Khandelwal, www.kapilkhandelwal.com Kapil Khandelwal (KK)
My Fortnightly column, A Dose of IT that discusses the genomic opportunity for creating a Bio Health Network
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
My fortnightly column, A Dose of IT that discusses on various issues to manage chronic diseases in India
Kapil Khandelwal
QuoteUnquote with KK
www.kapilkhandelwal.com
Its time for BDA to wake up to reality : Kapil Khandelwal, www.kapilkhandelwa...Kapil Khandelwal (KK)
My fortnightly column, A Dose of IT discusses on Urban census and public health and well being
Kapil Khandelwal
www.kapilkhandelwal.com
QuoteUnquote with KK
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound